Results from our group showed that stimulation of AT2R in metastatic cancer cells is associated with activation of PTP1B, reduction of pY14-CAV1 levels, Rab5/Rac1 activity, and inhibition of migration, invasion, and metastasis [34]. The gene discussed is PTPN1; the disease is cancer.